
Quotient Limited QTNT
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited EV/EBITDA 2011-2025 | QTNT
EV/EBITDA Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.32 | -11.9 | -8.73 | -3.95 | -4.14 | -4.13 | -6.69 | -16.6 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -3.95 | -16.6 | -7.68 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
-43.6 | $ 18.94 | -0.21 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 20.99 | 1.77 % | $ 226 M | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 0.17 | -7.36 % | $ 4.99 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 39.2 | -0.28 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
20.1 | $ 229.76 | -0.39 % | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
-1.05 | $ 10.67 | -0.28 % | $ 303 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.53 | 2.0 % | $ 1.94 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | $ 101.87 | -0.03 % | $ 18.9 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
DexCom
DXCM
|
39.5 | $ 66.72 | -0.51 % | $ 25.8 B | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 26.24 | -0.94 % | $ 793 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 18.93 | -0.73 % | $ 1.02 B | ||
|
Celcuity
CELC
|
-2.38 | $ 99.81 | -0.11 % | $ 3.94 B | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 3.15 | 1.11 % | $ 100 K | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 226.38 | -0.58 % | $ 41 B | ||
|
Guardant Health
GH
|
-28.8 | $ 102.5 | 1.89 % | $ 12.6 B | ||
|
NeoGenomics
NEO
|
-33.5 | $ 12.06 | -1.43 % | $ 1.53 B | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 6.16 | -0.24 % | $ 558 M | ||
|
ENDRA Life Sciences
NDRA
|
0.831 | $ 4.6 | -3.36 % | $ 2.47 M | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 7.05 | -0.07 % | $ 1.53 B | ||
|
Koninklijke Philips N.V.
PHG
|
55.6 | $ 27.18 | -0.73 % | $ 20 B | ||
|
Personalis
PSNL
|
-7.07 | $ 8.09 | 1.51 % | $ 479 M | ||
|
Quidel Corporation
QDEL
|
9.16 | $ 28.89 | -1.4 % | $ 1.22 B | ||
|
National Research Corporation
NRC
|
21 | $ 18.6 | -0.29 % | $ 456 M | ||
|
RadNet
RDNT
|
17.6 | $ 71.29 | -0.28 % | $ 5.21 B | ||
|
Illumina
ILMN
|
70.5 | $ 131.43 | -1.0 % | $ 20.9 B | ||
|
Charles River Laboratories International
CRL
|
22 | $ 200.55 | -0.71 % | $ 10.3 B | ||
|
Soleno Therapeutics
SLNO
|
0.12 | $ 45.83 | -0.99 % | $ 1.84 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 174.36 | -0.64 % | $ 19.4 B | ||
|
Biodesix
BDSX
|
-4.25 | $ 6.73 | 0.07 % | $ 873 M | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 251.76 | -0.52 % | $ 21.1 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 182.23 | -0.42 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 679.89 | -0.36 % | $ 56.1 B | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 66.93 | -0.34 % | $ 4.63 B |